Stock BTI BIOASIS TECHNOLOGIES INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Bioasis Technologies Inc.

Equities

BTI

CA09064N1033

Biotechnology & Medical Research

Delayed Toronto S.E.
Other stock markets
 12:00:00 2024-03-21 pm EDT 		5-day change 1st Jan Change
0.005 CAD -.--% Intraday chart for Bioasis Technologies Inc. -.--% -.--%
2023 Bioasis Technologies Inc. Announces Terminating the Non-Exclusive Research Collaboration and Licensing Agreement with Chiesi Farmaceutici S.P.A CI
2023 Bioasis Technologies Slumps 25% As Provides Update on Financial Position MT

Valuation

Fiscal Period: February 2017 2018 2019 2020 2021 2022
Capitalization 1 43.37 32.6 25.19 14.62 25.86 19.32
Enterprise Value (EV) 1 42.82 31.92 23.83 15.05 23.24 19.49
P/E ratio -14.4 x -6.04 x -7.02 x -3.53 x 35.1 x -6.46 x
Yield - - - - - -
Capitalization / Revenue 84.6 x 55.3 x 17.7 x 24.1 x 6.34 x 512 x
EV / Revenue 83.5 x 54.1 x 16.8 x 24.8 x 5.7 x 517 x
EV / EBITDA -14.6 x -6.11 x -4.98 x -3.32 x 70.6 x -5.5 x
EV / FCF -358 x -18 x -23.3 x -9.77 x 116 x -10.2 x
FCF Yield -0.28% -5.55% -4.29% -10.2% 0.86% -9.82%
Price to Book 119 x 75.1 x -46.1 x -5.88 x 63.8 x -10.1 x
Nbr of stocks (in thousands) 45,654 51,742 58,587 63,573 71,844 72,914
Reference price 2 0.9500 0.6300 0.4300 0.2300 0.3600 0.2650
Announcement Date 6/28/17 6/26/18 6/28/19 6/29/20 6/25/21 6/14/22
1CAD in Million2CAD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: February 2017 2018 2019 2020 2021 2022
Net sales 1 0.513 0.5898 1.422 0.6064 4.078 0.0377
EBITDA 1 -2.935 -5.221 -4.79 -4.536 0.329 -3.542
EBIT 1 -2.986 -5.277 -4.857 -4.602 0.2709 -3.597
Operating Margin -582.07% -894.69% -341.57% -758.87% 6.64% -9,534.21%
Earnings before Tax (EBT) 1 -2.991 -5.308 -3.473 -4.056 0.6984 -2.96
Net income 1 -2.991 -5.308 -3.473 -4.056 0.6984 -2.96
Net margin -583.04% -899.89% -244.26% -668.95% 17.13% -7,846.5%
EPS 2 -0.0659 -0.1043 -0.0613 -0.0651 0.0103 -0.0410
Free Cash Flow 1 -0.1196 -1.771 -1.022 -1.54 0.201 -1.915
FCF margin -23.31% -300.28% -71.88% -253.89% 4.93% -5,075.08%
FCF Conversion (EBITDA) - - - - 61.09% -
FCF Conversion (Net income) - - - - 28.78% -
Dividend per Share - - - - - -
Announcement Date 6/28/17 6/26/18 6/28/19 6/29/20 6/25/21 6/14/22
1CAD in Million2CAD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: February 2021 Q2 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q2 2023 Q3
Net sales 1 4.078 - - - - 0.0377 - - 0.1489
EBITDA - - - - - - - - -
EBIT 1 3.06 -0.8285 -0.88 - -1.186 -0.7763 -0.8458 - -0.6989
Operating Margin 75.03% - - - - -2,057.43% - - -469.22%
Earnings before Tax (EBT) 1 1.947 0.8975 -1.091 - -0.5803 -1.272 -0.5668 - -0.9857
Net income 1 1.947 0.8975 -1.091 -0.5406 -0.5803 -1.272 -0.5668 -1.09 -0.9857
Net margin 47.74% - - - - -3,372.36% - - -661.79%
EPS 2 0.0300 0.0100 -0.0200 - -0.0100 -0.0200 -0.0100 - -0.0100
Dividend per Share - - - - - - - - -
Announcement Date 10/29/20 1/27/21 6/25/21 7/29/21 10/28/21 1/20/22 6/14/22 10/28/22 1/19/23
1CAD in Million2CAD
Estimates

Balance Sheet Analysis

Fiscal Period: February 2017 2018 2019 2020 2021 2022
Net Debt 1 - - - 0.43 - 0.17
Net Cash position 1 0.55 0.68 1.36 - 2.62 -
Leverage (Debt/EBITDA) - - - -0.0942 x - -0.0483 x
Free Cash Flow 1 -0.12 -1.77 -1.02 -1.54 0.2 -1.91
ROE (net income / shareholders' equity) -287% -1,331% 6,174% 267% -67.2% 392%
ROA (Net income/ Total Assets) -114% -283% -205% -214% 8.03% -81.1%
Assets 1 2.615 1.877 1.696 1.894 8.701 3.649
Book Value Per Share 2 0.0100 0.0100 -0.0100 -0.0400 0.0100 -0.0300
Cash Flow per Share 2 0.0100 0.0100 0.0200 0.0100 0.0400 0.0200
Capex - 0.04 0 - - -
Capex / Sales - 7.38% 0.15% - - -
Announcement Date 6/28/17 6/26/18 6/28/19 6/29/20 6/25/21 6/14/22
1CAD in Million2CAD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
BIOASIS TECHNOLOGIES INC. Stock Bioasis Technologies Inc.
-.--% 290K
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+1.51% 42.75B
LONZA GROUP AG Stock Lonza Group AG
+49.22% 41.61B
MODERNA, INC. Stock Moderna, Inc.
+8.57% 41.34B
CELLTRION, INC. Stock Celltrion, Inc.
-12.36% 26.59B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+8.92% 25.49B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-25.13% 18.12B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+29.17% 12.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-3.12% 11.76B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+6.35% 11B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. BTI Stock
  4. Financials Bioasis Technologies Inc.